Cephulac and Tylenol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cephulac (lactulose) and Tylenol (acetaminophen). Common drug interactions include hypersomnia among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Cephulac and Tylenol. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Cephulac?
Cephulac has active ingredients of lactulose. eHealthMe is studying from 136 Cephulac users. Check the latest studies of Cephulac.
What is Tylenol?
Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,310 Tylenol users. Check the latest studies of Tylenol.
19 people who take Cephulac and Tylenol together, and have interactions are studied.

What are the common drug interactions of Cephulac and Tylenol, by gender? *:
female:
- Hypersomnia (excessive daytime sleepiness (eds))
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Nausea (feeling of having an urge to vomit)
- Abdominal discomfort
- Diarrhoea
- Asthenia (weakness)
- Atelectasis (partial or complete collapse of the lung)
- Cardiac failure
- Cardiomegaly (increased size of heart than normal)
- Dehydration (dryness resulting from the removal of water)
male:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Post procedural haematoma (post procedural clotting of blood)
- Hepatitis c
- Hyperhidrosis (abnormally increased sweating)
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Chills (felling of cold)
- Cough
- Drug ineffective
- Dyspnoea exertional (breathlessness or shortness of breath)
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
What are the common drug interactions of Cephulac and Tylenol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Hypersomnia (excessive daytime sleepiness (eds))
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Abdominal discomfort
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Adverse drug reaction
- Hypophagia (reduced food intake)
20-29:
- Chills (felling of cold)
- Cough
- Dyspnoea exertional (breathlessness or shortness of breath)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hyperhidrosis (abnormally increased sweating)
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
30-39:
- Back pain
- Bowel movement irregularity
- Constipation
- Drug dependence
40-49:
- Hepatic failure (liver failure)
- Obesity (having too much body fat)
- Pancreatitis (inflammation of pancreas)
- Renal failure (kidney dysfunction)
- Abdominal pain upper
- Abscess neck (neck abscesses)
- Addison's disease (addison's disease, a hormonal disorder disease)
- Adrenal disorder
- Aphagia (inability or refusal to swallow)
- Asthenia (weakness)
50-59:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
60+:
- Atelectasis (partial or complete collapse of the lung)
- Cardiac failure
- Asthenia (weakness)
- Bundle branch block (disruption in the normal flow of electrical pulses that drive the heart beat)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Death
- Drug administration error
- Drug ineffective
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Faecal occult blood positive
What are the existing conditions these people have? *
- Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule): 5 people, 26.32%
- Haemorrhage (bleeding): 5 people, 26.32%
- Constipation: 4 people, 21.05%
- Nausea And Vomiting: 3 people, 15.79%
- Nausea (feeling of having an urge to vomit): 3 people, 15.79%
- Fever: 3 people, 15.79%
- Itching: 2 people, 10.53%
- Hypersensitivity: 2 people, 10.53%
- Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 2 people, 10.53%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Cephulac and Tylenol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cephulac and Tylenol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cephulac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tylenol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cephulac and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tylenol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lactulose and acetaminophen (the active ingredients of Cephulac and Tylenol, respectively), and Cephulac and Tylenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pravastatin Sodium and Prevacid drug interactions for men aged 50-59 - 6 seconds ago
- Could Nitro-Dur cause Atelectasis? - 7 seconds ago
- Could Quinine Sulfate cause Lacrimation Increased? - 14 seconds ago
- Septic Shock and drugs of ingredients of ado-trastuzumab emtansine - 25 seconds ago
- Abdominal Pain and drugs of ingredients of sparsentan - 27 seconds ago
- Blood Immunoglobulin G Decreased and drugs of ingredients of darbepoetin alfa - 29 seconds ago
- Drug interactions of Doxycycline and Chestnut - a minute ago
- Osteopenia and drugs of ingredients of nisoldipine - a minute ago
- Skin Blushing/Flushing and drugs of ingredients of pimecrolimus - a minute ago
- High Blood Pressure and Nail Abnormalities - a minute ago